Aiming for better clinical effectiveness
WASHINGTON, D.C.—The Patient-Centered Outcomes Research Institute (PCORI) board of governors will be awarding $97.9 million to fund 11 studies that will compare different approaches to improving care for several health conditions.
Roughly $38 million was approved for five studies to better the treatment of multiple sclerosis, which will look at MS-related fatigue and ways to help patients who present with increasingly severe symptoms. The board also allotted $32.8 million for three studies to look at ameliorating swallowing problems for patients undergoing radiation therapy for head and neck cancer, determining which of two common preoperative antiseptic skin solutions is best for reducing hospital-acquired surgical-site infections and comparing the effectiveness of two cavity-prevention techniques.
In addition, $18 million was earmarked for two projects looking at treatment for juvenile sickle cell disease patients moving to adult care, and the board approved $8.8 million for a study on opioid use among patients with chronic pain and therapy options for reducing opioid use and pain.
Including this batch of awards, PCORI’s board has now approved $1.9 billion to fund more than 600 patient-centered clinical effectiveness research studies and related projects since 2012.